DR CLAUDE A. FARRUGIA
DEPARTMENT OF CHEMISTRY

Publications in refereed journals

  • Farrugia, C.A.: Controlled temperature storage of medicinals: good practice measures in the community pharmacy. The Chronic*ill 10: 30-33, 2005.
  • Farrugia, C.A.: Flow-Through Dissolution Testing: A Comparison with Stirred Beaker Methods. The Chronic*ill 6: 27-29, 2002.
  • Farrugia, C.A.: The Antiplatelet Activity of Aspirin. The Chronic*ill 3: 21-25, 1999.
  • Farrugia, C.A., and Groves, M.J.: Gelatin Behaviour in Dilute Aqueous Solution: Designing a Nanoparticulate Formulation. Journal of Pharmacy and Pharmacolology 51: 643-649, 1999
  • Farrugia, C.A., and Groves, M.J.: The Activity of Unloaded Gelatin Nanoparticles on Murine B16-F0 Melanoma Growth In Vivo. Anticancer Research 19: 1027-1032, 1999
  • Farrugia, C.A., Farrugia I.V., and Groves, M.J.: Comparison of the Molecular Weight Distribution of Gelatin Fractions by Size-Exclusion Chromatography and Light Scattering. Pharmacy and Pharmacology Communications 4: 1-5, 1998
  • Farrugia, C.A., Zarb Adami, M., Gatt, M., and Serracino Inglott, A.: Impact of a Computerized Medication Record System on Length of Hospitalisation. International Pharmacy Journal 6: 69-71, 1992


    • Conference contributions

  • Storm, J., Farrugia, C.A., and Sinagra, E.: The Effect of Sodium Chloride on the pH-dependant Ethanolic Fractionation of Gelatin-SDS Mixtures. (Presented at the Fifth World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Geneva, 2006)
  • Storm, J., Farrugia, C.A., and Sinagra, E.: The Effect of Sodium Dodecyl Sulfate on the Ethanolic Fractionation of Dilute Gelatin Solutions. (Presented at the Fifth World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Geneva, 2006)
  • Cortis, R., Farrugia, C.A., and Sinagra, E.: The Role of Electrostatic Interactions in the Desolvation of Isoionic Gelatin Solutions. (Presented at the Third National Chemistry Symposium, Department of Chemistry, University of Malta, 2006)
  • Farrugia, C.A.: Euromed Pharmaceutical Industry: Applying national experiences to regional development. (Presented at the Euro-Mediterranean Investment Summit, Marseille, 2005)
  • Blei, C., Farrugia, C.A., Mifsud, J., and Sinagra, E.: Potentiometric Studies on Gelatin Solutions and Gelatin Nanoparticle Dispersions. (Presented at the International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Nuremberg, 2004)
  • Aquilina, A., Muller, D., Farrugia, C.A., and Sinagra, E.: The Effect of Sodium Chloride on Type-Based Differences in Gelatin Desolvation Behaviour. (Presented at the International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Nuremberg, 2004)
  • Mifsud, J., Farrugia, C.A., and Sinagra, E.: Gelatin Nanoparticle Production: An In-Process Study Using Size Exclusion Chromatography. (Presented at the Second National Chemistry Symposium, Department of Chemistry, University of Malta, 2004)
  • Aquilina, A., Farrugia, C.A., and Sinagra, E.: The Effect of Sodium Chloride on Ethanolic Fractionation of Dilute Gelatin Solutions. (Presented at the Fourth World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Firenze, 2002)
  • Aquilina, A., Farrugia, C.A., and Sinagra, E.: Ethanolic Fractionation of Gelatin Solutions. (Presented by at the First National Chemistry Symposium, Department of Chemistry, University of Malta, 2002)
  • Farrugia, C.A., and Groves, M.J.: Inhibition of In Vivo Murine Melanoma Growth Using Gelatin Nanoparticles. (Presented at the Fifth International Symposium on Predictive Oncology and Therapy, Geneva, 2000)
  • Farrugia, C.A., and Groves, M.J.: Deconvolution of Complex Chromatograms: A Case Study of Gelatin. (Presented at the Third World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Berlin, 2000)
  • Farrugia, C.A., and Groves, M.J.: The Formulation of Gelatin Nanoparticles and their Effect on Melanoma Growth In Vivo. (Presented at the Fourth Maltese Medical School Conference, Faculty of Medicine and Surgery, University of Malta, 1999)
  • Farrugia, C.A., and Groves, M.J.: Effect of Molecular Weight Profile on Gelatin Nanoparticulate Formation. PharmSci 1: S-195, 1998 (Presented at the American Association of Pharmaceutical Scientists Annual Meeting and Exposition, San Francisco, 1998)
  • Farrugia, C.A., and Groves, M.J.: The Effect of Ethanol and Sodium Sulfate on the Molecular Behavior of Gelatin. Acta Pharmaceutica Turcica 40: S-53, 1998 (Presented at the First International Postgraduate Research Symposium on Pharmaceutics, Istanbul, 1998)
  • Farrugia, C.A., and Groves, M.J.: Gelatin Denaturation and Renaturation Processes in Solution. Pharmaceutical Research 14: S-160, 1997 (Presented at the American Association of Pharmaceutical Scientists Annual Meeting and Exposition, Boston, 1997)
  • Farrugia, C.A., and Groves, M.J.: The Effect of BCG, BCG Filtrate, and an Immunostimulant Derived From BCG on the B16-F1 Melanoma Cell Line both In Vitro and In Vivo. (Presented at the Second Annual Student and Resident Research Poster Forum, College of Pharmacy, University of Illinois at Chicago, 1996)


    • Other publications

  • Farrugia, C.A.: The pharmaceutical manufacturing industry: a look to the future. Industry Today 56: 40-41, 2005
  • Farrugia, C.A.: Quality in Pharmaceutical Manufacturing: a Review of European Union Legislation. EPSA Newsletter 8: 21-22, 2000
  • Farrugia, C.A.: The Formulation of Biotechnology Products. EPSA Newsletter 7: 18-19, 1999